Back to results
US 5,472,983 AGranted
Benzamide-containing pharmaceutical compositions
AssigneeCentaur Pharmaceuticals, Inc.
InventorsWilliam D. Flitter, Kirk R. Maples, Richard E. Paylor, Helming Tan, Allan L. Wilcox
Life of this patent
Estimating the term…
Abstract
A group of benzamide compounds are disclosed that are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from neurodegenerative conditions associated with dopamine depletion.
Claims19
A pharmaceutical composition comprising a benzamide compound selected from the group consisting of
- N-(carboxymethyl) 4-nitrobenzamide,
- N-phenyl trimethylacetamide,
- N-isobutyl 3,5-dinitrobenzamide,
- N-tert-butyl benzamide,
- N-tert-butyl 4-nitrobenzamide,
- N-tert-butyl 4-bromobenzamide,
- N-tert-butyl 4-methylbenzamide,
- N-tert-butyl 4-cyanobenzamide,
- N-tert-butyl 3,5-dinitrobenzamide,
- N-tert-butyl-N-methyl 4-nitrobenzamide, and
- N-tert-butyl 4-nitrobenzthioamide
- in a pharmaceutically acceptable carrier.
9 more elements
Dependencies are inferred from the claim text.